Foreign-invested Pharmaceutical Companies In China Collectively Take Green Measures
This article was originally published in PharmAsia News
Executive Summary
Members of the China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee, such as Johnson & Johnson, Bayer HealthCare and Abbott, are annually increasing investment in emissions reduction and environmental protection in China